No Record Found
Sector
PharmaceuticalsOpen
₹2,020Prev. Close
₹2,005.4Turnover(Lac.)
₹1,167.54Day's High
₹2,046.3Day's Low
₹2,00052 Week's High
₹2,64152 Week's Low
₹1,599Book Value
₹238.85Face Value
₹2Mkt Cap (₹ Cr.)
15,400.73P/E
43.61EPS
46.42Divi. Yield
0.2730 Jul 2025
12:00 AM
Board Meeting
Agenda : Audited Result
7 Aug 2025
12:00 AM
AGM
Announcement Date: 07 Aug, 2025
The drug is the generic alternative of the Vitamin K1 Injection produced by Hospira Inc and is indicated in the treatment of Vitamin K deficiency-related coagulation disorders.
Here are some of the stocks that may see significant price movement today: ICICI Prudential, Caplin Point, Ashoka Buildcon, etc.
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 15.19 | 15.18 | 15.16 | 15.13 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,374.96 | 1,124.73 | 915.49 | 743.54 |
Net Worth | 1,390.15 | 1,139.91 | 930.65 | 758.67 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 482.67 | 527.82 | 426.57 | 341.54 |
yoy growth (%) | -8.55 | 23.73 | 24.89 | 47.67 |
Raw materials | -194.83 | -238.17 | -180.11 | -161.93 |
As % of sales | 40.36 | 45.12 | 42.22 | 47.41 |
Employee costs | -26.59 | -24.99 | -38.82 | -30.58 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 209.93 | 253.12 | 146.05 | 92.57 |
Depreciation | -22.44 | -19.65 | -18.98 | -13.25 |
Tax paid | -53.71 | -55.48 | -43.74 | -22.26 |
Working capital | 168.2 | 177.62 | 44.02 | 40.41 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -8.55 | 23.73 | 24.89 | 47.67 |
Op profit growth | 3.34 | 45.98 | 51.72 | 49.97 |
EBIT growth | -17.05 | 73.36 | 57.61 | 58.5 |
Net profit growth | -20.95 | 93.17 | 45.49 | 55.13 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 1,937.47 | 1,694.1 | 1,466.73 | 1,269.41 | 1,061.29 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,937.47 | 1,694.1 | 1,466.73 | 1,269.41 | 1,061.29 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 96.43 | 67.21 | 56.06 | 38.75 | 23.54 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,631.2 | 78.71 | 3,92,063.33 | 753.53 | 0.98 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 5,866 | 66.67 | 1,55,749.09 | 557 | 0.51 | 2,357 | 561.08 |
Cipla Ltd CIPLA | 1,517.7 | 23.7 | 1,22,429.01 | 1,303.13 | 1.06 | 4,501.66 | 397.38 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,514.7 | 59.82 | 1,18,922.69 | 551 | 0.17 | 2,567 | 224.34 |
Dr Reddys Laboratories Ltd DRREDDY | 1,248.1 | 15.11 | 1,04,168.14 | 2,961.2 | 0.64 | 7,788.7 | 345.74 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Non Executive Dir.
C C Paarthipan
Non Independent Executive Director / MD
Sridhar Ganesan
Independent Non Exe. Director
R Vijayaraghavan
Independent Non Exe. Director
C K Gariyali
Independent Non Exe. Director
Deenadayalan Singaram
Independent Non Exe. Director
R Nagendran
Co. Sec. / Comp. Officer / General Counsel
VENKATRAM GANAPATHYSUBRAMANIAN
Ashvich Towers 3rd Floor,
No 3 Developed Plots Ind Estat,
Tamil Nadu - 600096
Tel: 91-44-24968000/71148000/28156653
Website: http://www.caplinpoint.net
Email: investor@caplinpoint.net; info@caplinpoint.net
2nd Floor Kences Tow,
1 Ramakrishna Street, Usman Road T.Nagar,
Chennai-600017
Tel: 91-44-28140801/803
Website: www.integratedindia.in
Email: sureshbabu@iepindia.com/yesbalu@iepindia.com
Summary
Promoted by Mr. C. C. Paarthipan, Caplin Point Laboratories Limited was incorporated on April 16, 1990. The Company is presently into the business of pharmaceuticals like producing, developing and mar...
Read More
Reports by Caplin Point Laboratories Ltd
What is the Caplin Point Laboratories Ltd share price today?
What is the Market Cap of Caplin Point Laboratories Ltd?
What is the PE and PB ratio of Caplin Point Laboratories Ltd?
What is the 52 Week High and Low of Caplin Point Laboratories Ltd?
What is the CAGR of Caplin Point Laboratories Ltd?
What is the shareholding pattern of Caplin Point Laboratories Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
